Mitchell Chan - Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mitchell Chan since 10/12/2024

Holdings reported by Mitchell Chan for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 6.33K $53.6K $8.46 Mar 28, 2025 Direct Common Stock
Common Stock 3.17K $26.8K $8.46 Mar 28, 2025 Direct
Stock Option (Right to Buy) 20.1K Jun 17, 2025 Direct Common Stock

Transactions reported by Mitchell Chan for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.